Bioventus BVS
NASDAQ BVS
$14.39 -0.29 (-1.98%)
At close: Aug 20, 2026 · 12:13 PM UTC

Bioventus (BVS) Total Debt Growth (5y) (2025 - 2026)

Bioventus (BVS) Total Debt Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn
10 Bioventus 975.28 Mn 945.82 Mn 105.67 Mn

Historic Data

Download Data
DateValue
Jun 27, 2026 6.53%
Mar 28, 2026 8.05%
Dec 31, 2025 9.31%